Shoulder injury following COVID-19 vaccine administration: a case series and proposed diagnostic algorithm

Figures & data

Figure 1. Diagnostic criteria for SIRVA.

Figure 2. Suspected SIRVA cases: Patient Demographics (Age).

Table 1. Clinical features of SIRVA cases.

Onset of pain			Medical follow-up*			Imaging investigations			Diagnosis on imaging			Length of time to symptom resolution		Medication**
	N	%		N	%		N	%		N	%	Age group	Median no. of days		N	%
Immediate/rapid	50	33.1%	GP	123	81.5%	X-ray	24	15.9%	Bursitis	56	68.3%	18–49 years	35 days	OTC	122	80.8%
Within 24hrs	112	74.2%	Allied health	75	49.7%	Ultrasound	91	60.3%	Adhesive capsulitis	19	23.2%	50–64 years	90 days	Prescription medication	37	24.5%
Within 48hrs	125	82.8%	Specialist	16	13.9%	MRI	19	12.6%				64+ years	45 days	Cortisone injection	37	24.5%
						None	47	31.1%				No resolution at time of follow-up	80 (53.0%)

(MRI: multi-resonant Imaging, OTC: Over the counter medication)

** Figures include patients who may have had multiple different types of medical follow-up or taken multiple different medications.

Figure 3. Negative impact on day-to-day functioning.

Figure 4. Proposed SIRVA Investigation & Management Algorithm.